Health Care & Life Sciences » Biotechnology | Holista CollTech Ltd.

Holista CollTech Ltd. | Balance Sheet

Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,574.00
1,511.60
497.80
777.20
538.20
357.70
Total Accounts Receivable
1,175.20
1,225.40
1,782.30
1,225.30
1,807.10
3,019
Inventories
617.80
695.70
1,010.70
1,021.30
956.20
442.60
Other Current Assets
170.80
186.70
179.60
532.90
459.60
978.80
Total Current Assets
5,537.80
3,619.40
3,470.40
3,556.80
3,761.10
4,798.10
Net Property, Plant & Equipment
2,376.20
1,374.80
1,305.50
1,069.60
1,557.40
1,429.10
Total Investments and Advances
3.10
23.60
-
389.00
-
-
Long-Term Note Receivable
-
-
16.30
8.70
343.90
13.80
Intangible Assets
189.20
188.90
189.20
75.70
858.80
954.70
Total Assets
8,106.30
5,243.60
4,981.30
5,241.10
6,813.80
7,427.40
ST Debt & Current Portion LT Debt
2,628.90
1,101.00
773.00
305.60
223.00
Accounts Payable
771.50
290.00
459.00
438.80
746.70
Income Tax Payable
-
-
114.90
50.10
7.60
Other Current Liabilities
547.80
416.60
667.10
833.30
1,819.10
Total Current Liabilities
3,948.20
1,807.60
2,014.10
1,627.80
2,796.30
Long-Term Debt
2,509.30
2,319.10
813.50
605.30
533.90
Deferred Taxes
-
36.80
-
141.40
292.50
Total Liabilities
6,457.50
4,126.70
2,827.60
2,233.10
3,330.20
Common Equity (Total)
1,648.80
1,215.50
2,346.20
3,207.60
3,677.10
Total Shareholders' Equity
1,648.80
1,215.50
2,346.20
3,207.60
3,677.10
Total Equity
1,648.80
1,116.90
2,153.70
3,008.00
3,483.50
Liabilities & Shareholders' Equity
8,106.30
5,243.60
4,981.30
5,241.10
6,813.80
Accumulated Minority Interest
-
98.60
192.50
199.50
193.60

About Holista CollTech

View Profile
Address
283 Rokeby Road
Subiaco Western Australia (WA) 6008
Australia
Employees -
Website http://www.holistaco.com
Updated 07/08/2019
Holista CollTech Ltd. is a research-driven biotech company, which engages in researching, developing, manufacturing and marketing health style products to address the unmet and growing needs of natural medicine. It operates its business through the following segments: Supplements, Sheep Collagen, and Food Ingredients. The Supplements segment manufactures and sells dietary supplements.